News Daily News US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines Todd Neale May 24, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News ACC 2021 RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients Todd Neale May 17, 2021
News Conference News EHRA 2021 His-Bundle Pacing Gains Support in Pilot Study Todd Neale April 28, 2021
News Conference News EHRA 2021 RACE 3: Effects Wane for Targeted Therapy in Early AF, HF Todd Neale April 26, 2021
News Daily News Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations Todd Neale March 04, 2021
News Daily News New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF Todd Neale February 16, 2021
News Daily News CABANA Supports Use of AF Ablation in Patients With Heart Failure Todd Neale February 12, 2021
News Opinion Editor's Corner Envision Change: A Different Future for Cardiology, Medicine, Research, and Health Shelley Wood December 29, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Conference News AHA 2020 INVESTED: No Added CV Benefit From High-Dose Flu Vaccine Todd Neale November 17, 2020
News Conference News AHA 2020 Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF Todd Neale November 16, 2020
News Conference News AHA 2020 Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF Todd Neale November 13, 2020
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Daily News As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes Todd Neale September 23, 2020
News Conference News ESC 2020 PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF Todd Neale August 30, 2020
News Daily News ‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults Todd Neale August 17, 2020